Skip to main content

Table 2 Pathogenic organisms isolated from 1,895 patients with bloodstream infections between 2019 and 2020*

From: Blood culture utilization and epidemiology of antimicrobial-resistant bloodstream infections before and during the COVID-19 pandemic in the Indonesian national referral hospital

Pathogens

Year 2019 (N = 828)

Year 2020 (N = 1067)

P values

Non COVID-19 cases (N = 1838)

COVID-19 cases** (N = 57)

P values

Gram negative bacteria

Escherichia coli

115 (13.9%)

115 (10.7%)

0.04

221 (12%)

9 (15.8%)

0.39

Klebsiella pneumonia

201 (24.3%)

207 (19.4%)

0.01

398 (21.7%)

10(17.5%)

0.45

Klebsiella spp

16 (1.9%)

18 (1.7%)

0.69

32 (1.7%)

2 (3.5%)

0.32

Proteus spp

7 (0.9%)

12 (1.1%)

0.54

19 (1%)

0 (0%)

0.44

Salmonella spp

21 (2.5%)

12 (1.1%)

0.02

33 (1.8%)

0 (0%)

0.62

Salmonella enterica

3 (0.4%)

1 (0.1%)

0.32

4 (0.2%)

0 (0%)

> 0.99

S. enterica serovar typhi

2 (0.2%)

4 (0.4%)

0.70

5 (0.3%)

1 (1.8%)

0.05

Shigella spp

1 (0.1%)

0 (0%)

0.43

1 (0.1%)

0 (0%)

> 0.99

Pseudomonas aeruginosa

59 (7.1%)

98 (9.2%)

0.10

152 (8.3%)

5 (8.8%)

0.89

Pseudomonas spp

1 (0.1%)

3 (0.3%)

0.63

4 (0.2%)

0 (0%)

> 0.99

Acinetobacter spp

102 (12.3%)

151 (14.1%)

0.24

245 (13.3%)

8 (14%)

0.87

Aeromonas spp

5 (0.6%)

5 (0.5%)

0.75

10 (0.5%)

0 (0%)

> 0.99

Burkholderia cepacia

6 (0.8%)

7 (0.7%)

0.85

13 (0.7%)

0 (0%)

> 0.99

Citrobacter spp

4 (0.5%)

3 (0.3%)

0.70

7 (0.4%)

0 (0%)

> 0.99

Serratia spp

11 (1.3%)

6 (0.6%)

0.07

17 (0.9%)

0 (0%)

> 0.99

Other Gram-negative bacteria

63 (7.6%)

83 (7.7%)

0.89

143 (7.8%)

3 (5.3%)

0.48

Gram positive bacteria

Staphylococcus aureus

88 (10.6%)

128 (12%)

0.35

213 (11.6%)

3 (5.3%)

0.13

Streptococcus pneumoniae

2 (0.2%)

1 (0.1%)

0.58

2 (0.1%)

1 (1.8%)

0.08

Streptococcus pyogenes

2 (0.2%)

(0.2%)

> 0.99

4 (0.2%)

0 (0%)

> 0.99

Enterococcus faecium

6 (0.8%)

5 (0.5%)

0.54

11 (0.6%)

0 (0%)

> 0.99

Enterococcus faecalis

22 (2.7%)

39 (3.6%)

0.22

55 (3.0%)

6 (10.4%)

0.01

Lactococcus garvieae

0 (0%)

1 (0.1%)

> 0.99

1 (0.1%)

0 (0%)

> 0.99

Fungi

Candida albicans

7 (0.9%)

30 (2.8%)

0.01

34 (1.8%)

3 (5.3%)

0.67

Non-albicans Candida spp

53 (6.4%)

110 (10.3%)

0.01

157 (8.5%)

6 (10.5%)

0.59

Cryptococcus spp

2 (0.2%)

0 (0%)

0.19

2 (0.1%)

0 (0%)

> 0.99

Other fungi

0 (0%)

3 (0.3%)

0.26

3 (0.3%)

0 (0%)

> 0.99

Polymicrobial infections***

29 (3.5%)

23 (2.2%)

0.07

52 (2.8%)

0 (0%)

0.40

  1. BSI Bloodstream infections
  2. *Only the first pathogenic isolate per patient during the study period was included
  3. **All COVID-19 cases were in 2020
  4. ***Three most common polymicrobial infections were Escherichia coli + Klebsiella pneumoniae (10 patients), Klebsiella pneumoniae + Other Gram-negative bacteria (10 patients), Acinetobacter spp. + Klebsiella pneumoniae (7 patients). Polymicrobial infections are described in Addition file 1: Table S2